Brought to you by 
Sequenom gains rights to Univ. of Oxford's prenatal test IP
28 Oct 2005
Executive Summary
Isis Innovation, the tech transfer arm of the University of Oxford, has granted Sequenom (DNA analysis) exclusive rights in the US, Canada, France, Germany, the UK, and certain other European countries to prenatal diagnostic IP.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sequenom gains rights to Univ. of Oxford's prenatal test IP
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice